Assenagon Asset Management S.A. Intercept Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$19.33 - $37.75 $3.45 Million - $6.74 Million	-178,622 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$24.48 - $42.47 $8.12 Million - $14.1 Million	-331,878 Reduced 65.01%	178,622 $4.41 Million
Q3 2020 Oct 07, 2020	BUY	$39.09 - $53.44 $20 Million - $27.3 Million	510,500 New	510,500 $21.2 Million
Q1 2020 Apr 17, 2020	SELL	$48.35 - $118.68 $464,933 - $1.14 Million	-9,616 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$57.36 - $124.1 $551,573 - $1.19 Million	9,616 New	9,616 $1.19 Million
Q1 2019 Apr 26, 2019	SELL	$91.83 - $120.68 $2.04 Million - $2.68 Million	-22,180 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$85.79 - $126.46 $1.9 Million - $2.8 Million	22,180 New	22,180 $2.24 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.